Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Harvard Bioscience Inc Issues FY, Q4 2013 Revenue Guidance-Conference Call


Thursday, 31 Oct 2013 11:00am EDT 

Harvard Bioscience Inc announced that it expects revenue for fiscal 2013 to be down approximately 6% versus fiscal 2012 i.e. about $104 million. For fourth quarter of 2013, it expects revenue to be about $27 million -$28 million. The Company reported revenue of $111.17 million in fiscal 2012. 

Company Quote

6.22
0.08 +1.30%
24 Apr 2015